
Reset all filters
01 11Gowling WLG (Canada) LLP
Reset all filters
01 22420231
02 12626214
03 22687499
04 12745938
05 22898369
06 22947947
07 12993565
Reset all filters
01 6CANAKINUMAB
02 5Canakinumab
Reset all filters
01 5POWDER FOR SOLUTION
02 6SOLUTION
Reset all filters
01 22021-08-20
02 32026-10-24
03 52028-05-28
04 12029-12-09
Patent Expiration Date : 2021-08-20
Date Granted : 2011-04-26
Brand Name : ILARIS
Patent Number : 2420231
Filing Date : 2001-08-20
Strength per Unit : 150 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-08-20
Date Granted : 2011-04-26
Patent Expiration Date : 2026-10-24
Date Granted : 2016-06-21
Brand Name : ILARIS
Patent Number : 2626214
Filing Date : 2006-10-24
Strength per Unit : 150 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2026-10-24
Date Granted : 2016-06-21
Patent Expiration Date : 2021-08-20
Date Granted : 2011-04-26
Brand Name : ILARIS
Patent Number : 2420231
Filing Date : 2001-08-20
Strength per Unit : 150 mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2021-08-20
Date Granted : 2011-04-26
Patent Expiration Date : 2026-10-24
Date Granted : 2017-06-20
Brand Name : ILARIS
Patent Number : 2898369
Filing Date : 2006-10-24
Strength per Unit : 150 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2026-10-24
Date Granted : 2017-06-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-28
Date Granted : 2017-11-28
Brand Name : ILARIS
Patent Number : 2687499
Filing Date : 2008-05-28
Strength per Unit : 150 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2028-05-28
Date Granted : 2017-11-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-28
Date Granted : 2018-03-06
Brand Name : ILARIS
Patent Number : 2947947
Filing Date : 2008-05-28
Strength per Unit : 150 mg / mL
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2028-05-28
Date Granted : 2018-03-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-10-24
Date Granted : 2017-06-20
Brand Name : ILARIS
Patent Number : 2898369
Filing Date : 2006-10-24
Strength per Unit : 150 mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2026-10-24
Date Granted : 2017-06-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-28
Date Granted : 2017-11-28
Brand Name : ILARIS
Patent Number : 2687499
Filing Date : 2008-05-28
Strength per Unit : 150 mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-28
Date Granted : 2017-11-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-05-28
Date Granted : 2018-03-06
Brand Name : ILARIS
Patent Number : 2947947
Filing Date : 2008-05-28
Strength per Unit : 150 mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2028-05-28
Date Granted : 2018-03-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-09
Date Granted : 2018-04-24
Brand Name : ILARIS
Patent Number : 2745938
Filing Date : 2009-12-09
Strength per Unit : 150 mg / 1mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-09
Date Granted : 2018-04-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF